Abbott announces results of analysis exploring the use of HUMIRA® in simultaneously achieving three key treatment goals for RA
Results from a post-hoc analysis...
12 November 2012 | By Abbott
Results from a post-hoc analysis...
List view / Grid view
Results from a post-hoc analysis...
12 November 2012 | By Abbott
Results from a post-hoc analysis...
Abbott announced results from two long-term, open-label studies...
6 June 2012 | By Abbott
Abbott announced results from two long-term, open-label studies...